XBKK
BH
Market cap4.28bUSD
Nov 12, Last price
181.00THB
Name
Bumrungrad Hospital PCL
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Bumrungrad Hospital Public Company Limited (BUGDF) is a leading healthcare provider that operates a network of medical facilities in Thailand and globally. Its core offering is a comprehensive medical center equipped with advanced diagnostic, therapeutic, and intensive care capabilities. The company also boasts an extensive array of approximately 56 specialized outpatient clinics and centers, covering a broad spectrum of medical disciplines. These include, but are not limited to, allergy, cardiology, behavioral health, oncology, dental, diabetes, emergency services, eye care, fertility, digestive disease, women's health, men's health, orthopedics, physical therapy, plastic surgery, and sleep medicine. Beyond direct patient care, Bumrungrad engages in various related activities. These encompass managing real estate holdings, conducting clinical research, distributing pharmaceutical and medical goods through dedicated stores, operating a training and development center for healthcare professionals, and providing patient referral services. With its substantial infrastructure, the company maintains 580 hospital beds across its facilities. Founded in 1980, Bumrungrad Hospital Public Company Limited is headquartered in Bangkok, Thailand.
Key people
Non-Executive Chairman of the Board · since 2018
Artirat Charukitpipat
Chief Executive Officer · since 2020
Chanvit Tanphiphat
Non-Executive Vice Chairman of the Board · since 2018
Oraphan Buamuang
Chief Financial Officer · since 2019
Linda Lisahapanya
Managing Director, Executive Director
Aniello Sorrentino
Corporate Chief Strategy Officer · since 2022
Taveesin Tanprayoon
Chief Medical Officer · since 2020
Pantip Chirakarnjanakorn
Company Secretary · since 2017
Bernard Chan
Non-Executive Director · since 2017
Chanida Sophonpanich
Non-Executive Director · since 2024
Chong Toh
Non-Executive Director · since 2001
Anon Vangvasu
Non-Executive Director · since 2019
Independent Director · since 2012
Aruni Kettratad
Independent Director · since 2010
Mark Schatten
Independent Director · since 2021
Chanond Sophonpanich
Independent Director · since 2021
Independent Director · since 2001
Valuation
Title THB in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||